Depression and Anxiety in Patients with Bullous Pemphigoid: A Systematic Review and Narrative Synthesis.
- 1From the School of Medicine, Faculty of Health and Life Science, University of Liverpool, Liverpool, United Kingdom.
- 2School of Medicine and Population Health, Faculty of Health, University of Sheffield, Sheffield, United Kingdom.
- 3Department of Acute Medicine, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom.
Abstract
Background
Bullous pemphigoid (BP) is a chronic autoimmune blistering disorder associated with significant morbidity and mortality. BP has previously been linked to several neurological disorders; however, its relationship with depression and anxiety remains poorly understood.Objectives
This systematic review aimed to evaluate the prevalence, severity, and impact of depression and anxiety in patients with BP.Methods
Following PRISMA guidelines, a systematic search was conducted in PubMed, Embase, and PsycINFO up to August 2024. Studies involving adults (≥16 years) with BP reporting depression and/or anxiety outcomes were included. Experimental and observational peer-reviewed studies were considered. Two reviewers independently screened and extracted data on mental health prevalence, effect estimates, and study quality, assessed via the Newcastle-Ottawa Scale.Results
This review identified a high prevalence of mental health issues in patients with BP, with depression a seemingly more consistent and pronounced issue versus anxiety. Despite this, current UK guidance provides no provision for screening and treatment of mental health issues in patients with BP. Comorbid depression was linked to increased mortality and poorer treatment adherence, suggesting a bidirectional relationship.Conclusions
Integrating validated mental health screening tools such as PHQ-9 and GAD-7 in BP care is critical. A holistic approach addressing both dermatological and psychiatric aspects may improve outcomes and quality of life for BP patients.
Related
- Gut microbiome alterations and depression in patients with diabetes mellitus: a systematic review and narrative synthesis of the gut-metabolic-brain axis
- Echocardiographic findings in children with malaria: a systematic review and narrative synthesis
- Efficacy and Neural Mechanisms of Eye Movement Desensitization and Reprocessing (EMDR) for Depression: A Systematic Review and Qualitative Synthesis
- Artificial intelligence-enhanced electrocardiography for predicting mortality and major adverse cardiovascular events: A systematic review and narrative synthesis
- Marburg Virus Disease (MVD): a rapid systematic review with narrative synthesis of epidemiology, clinical presentation, diagnostics, management, and public-health response.
BibTeX
@article{baggus2026depression,
title = {{Depression and Anxiety in Patients with Bullous Pemphigoid: A Systematic Review and Narrative Synthesis.}},
author = {Elisabeth Megan Rose Baggus and Arwa Khashkhusha and Salsabeel Khashkhusha and Sundas Butt},
journal = {Indian journal of dermatology},
year = {2026},
month = oct,
doi = {10.4103/ijd.ijd_171_25},
url = {https://europepmc.org/article/MED/43011989},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Depression and Anxiety in Patients with Bullous Pemphigoid: A Systematic Review and Narrative Synthesis.
AU - Elisabeth Megan Rose Baggus
AU - Arwa Khashkhusha
AU - Salsabeel Khashkhusha
AU - Sundas Butt
PY - 2026
DA - 2026/10/30
JO - Indian journal of dermatology
DO - 10.4103/ijd.ijd_171_25
UR - https://europepmc.org/article/MED/43011989
AB - Background Bullous pemphigoid (BP) is a chronic autoimmune blistering disorder associated with significant morbidity and mortality. BP has previously been linked to several neurological disorders; however, its relationship with depression and anxiety remains poorly understood.Objectives This systematic review aimed to evaluate the prevalence, severity, and impact of depression and anxiety in patients with BP.Methods Following PRISMA guidelines, a systematic search was conducted in PubMed, Embase, and PsycINFO up to August 2024. Studies involving adults (≥16 years) with BP reporting depression and/or anxiety outcomes were included. Experimental and observational peer-reviewed studies were considered. Two reviewers independently screened and extracted data on mental health prevalence, effect estimates, and study quality, assessed via the Newcastle-Ottawa Scale.Results This review identified a high prevalence of mental health issues in patients with BP, with depression a seemingly more consistent and pronounced issue versus anxiety. Despite this, current UK guidance provides no provision for screening and treatment of mental health issues in patients with BP. Comorbid depression was linked to increased mortality and poorer treatment adherence, suggesting a bidirectional relationship.Conclusions Integrating validated mental health screening tools such as PHQ-9 and GAD-7 in BP care is critical. A holistic approach addressing both dermatological and psychiatric aspects may improve outcomes and quality of life for BP patients.
SN - 0019-5154
SN - 1998-3611
ER -